Axitrix T 250mg/31.25mg Injection
Marketer
Axis Life Science Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Axitrix T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg injection combats bacterial infections by inhibiting microbial proliferation. Administered only under medical supervision, this dual-action medication requires adherence to the prescribed treatment schedule. Premature cessation may compromise efficacy. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea, indigestion). Severe reactions or allergic symptoms (rash, itching, swelling, respiratory distress) demand immediate medical attention. Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration support recovery. Your doctor may order tests to monitor treatment effectiveness.
Uses of Axitrix T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Axitrix T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Axitrix T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Axitrix T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Axitrix T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum Injection (Axitrix T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactum counteracts bacterial resistance, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Axitrix T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Axitrix T (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Axitrix T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The injection Axitrix T (250mg/31.25mg) can cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Axitrix T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Axitrix T 250mg/31.25mg requires careful administration for individuals with significant hepatic impairment; dosage modification might be necessary. Medical advice is recommended. Altering the dose of Axitrix T 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Axitrix T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Axitrix T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Axitrix T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
3,018 People bought this recently